Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hims and Hers Health Inc (HIMS) vs VanEck Uranium & Nuclear ETF (NLR) Price & Performance

Hims and Hers Health IncTrade
VanEck Uranium & Nuclear ETFTrade

Price performance (Past 24H)

Key statistics

Hims and Hers Health Inc vs VanEck Uranium & Nuclear ETF — how do they compare? Hims and Hers Health Inc trades at $28.38 (market cap $6.89B), while VanEck Uranium & Nuclear ETF trades at $103.5 (market cap $3.61B). The key difference: Hims and Hers Health Inc is the larger of the two by market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, VanEck Uranium & Nuclear ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and VanEck Uranium & Nuclear ETF for 7 Days on average.

HIMSNLR
Market Cap
$6.89B$3.61B
Volume
5,446,628696,289
Sector
HealthSector/Thematic
52-Week High
$62.76$164.37
52-Week Low
$14.52$102.38
Typical Hold Time
21 Days7 Days
Enterprise Value
$7.60B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hims and Hers Health Inc

Hims & Hers Health trades at $29.54, up 0.24% on the day, with a bullish technical signal from moving averages but mixed earnings performance. Revenue grew to $2.35 billion in 2025, yet the company posted a net loss of $142 million in 2026, reflecting profitability challenges. High valuation ratios like a P/E of 57.14 and negative ROE of -32.03% indicate premium pricing despite weak earnings. Recent news highlights multiple securities class action lawsuits filed in October 2026, creating legal overhangs.

The stock faces headwinds from profitability struggles and legal risks, but analyst consensus remains a Buy with a $32.17 price target, suggesting modest upside. Investment appeal hinges on resolving operational inefficiencies and legal issues to align valuation with fundamentals, while current sentiment is cautious due to recent earnings misses and regulatory scrutiny.

VanEck Uranium & Nuclear ETF

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HIMS
86% Buy14% Sell
Avg holding period · 21 Days
NLR
9% Buy91% Sell
Avg holding period · 7 Days

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.

Read more on HIMS →

About VanEck Uranium & Nuclear ETF

VanEck Uranium and Nuclear ETF seeks exposure to companies involved in uranium mining and the nuclear power industry. Its holdings may include miners, utilities, reactor-related companies, and nuclear equipment or service providers.

Read more on NLR →